Medy-Tox (XKRX:086900) Accounts Payable & Accrued Expense : ₩36,049 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Accounts Payable & Accrued Expense?

Medy-Tox's quarterly accounts payable & accrued expense increased from Jun. 2023 (₩21,053 Mil) to Sep. 2023 (₩32,941 Mil) and increased from Sep. 2023 (₩32,941 Mil) to Dec. 2023 (₩36,049 Mil).

Medy-Tox's annual accounts payable & accrued expense declined from Dec. 2021 (₩26,380 Mil) to Dec. 2022 (₩23,155 Mil) but then increased from Dec. 2022 (₩23,155 Mil) to Dec. 2023 (₩36,049 Mil).

Medy-Tox Accounts Payable & Accrued Expense Historical Data

The historical data trend for Medy-Tox's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Accounts Payable & Accrued Expense Chart

Medy-Tox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

23,705.19

23,506.31

26,380.19

23,155.01

36,048.80

Medy-Tox Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															23,155.01	23,753.77	21,053.23	32,941.11	36,048.80

Medy-Tox Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Medy-Tox (XKRX:086900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines